B&L updates guidance
This article was originally published in The Tan Sheet
Executive Summary
Bausch & Lomb recall of MoistureLoc contact solution leads to an 8-K filing with the SEC to update information on its outstanding bank and public debt, Rochester, N.Y.-based firm announces Jan. 31. B&L also provides an updated financial forecast concerning its expectations for 2006 and 2007 sales and income. The firm currently expects sales of approximately $2.3 bil. reflecting "slower than anticipated rate of recovery" in Asia due to the recall. The firm also predicts full-year 2006 income before income taxes and minority interest as approximately $74 mil...
You may also be interested in...
Another ReNu Recall Begins While 2006 Episode Clouds B&L Earnings
Bausch & Lomb announced a voluntary recall of its ReNu MultiPlus contact lens solution the same day it reported the May 2006 worldwide recall of ReNu with MoistureLoc "led to declines in consolidated gross margins" for the full year
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.